Slatinska Banka d.d. (ZSE:SNBA)

Regulus Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	24.58	1.01	0.9	0.81	0.5	0.18
Depreciation & Amortization	1.03	0.72	0.6	0.37	0.38	0.45
Other Amortization	-	-	-	0.18	0.16	0.14
Gain (Loss) on Sale of Investments	0.02	-	-	0.41	1.12	0.56
Total Asset Writedown	0.57	0.24	0.83	0.01	-	1.13
Change in Trading Asset Securities	-1.94	-1.28	28.67	2.21	-4.81	1.47
Change in Other Net Operating Assets	-38.27	-3.84	-33.98	-7.6	3.86	8.48
Other Operating Activities	-6.5	11.26	9.48	-1.88	0.44	0.12
Operating Cash Flow	-20.52	8.12	6.5	-5.5	1.65	12.53
Operating Cash Flow Growth	-	24.92%	-	-	-86.83%	847.60%
Capital Expenditures	-1.52	-1.61	-1.2	-1.28	-	-0.63
Other Investing Activities	1.26	-	-	-	-	-
Investing Cash Flow	-5.43	-1.61	-1.2	-1.28	-	-0.63
Long-Term Debt Issued	-	4.06	-	0.12	-	5.74
Long-Term Debt Repaid	-	-0.28	-0.32	-0.52	-1.16	-0.09
Net Debt Issued (Repaid)	-0.81	3.78	-0.32	-0.4	-1.16	5.65
Net Increase (Decrease) in Deposit Accounts	17.94	11.44	5.21	9.86	5.32	-4.81
Other Financing Activities	-0.15	-	-0.25	-	-0.95	-
Financing Cash Flow	16.97	15.22	4.64	9.46	3.21	0.84
Net Cash Flow	-8.97	21.73	9.95	2.69	4.86	12.74
Free Cash Flow	-22.04	6.51	5.3	-6.78	1.65	11.9
Free Cash Flow Growth	-	22.76%	-	-	-86.14%	800.08%
Free Cash Flow Margin	-144.48%	62.27%	56.16%	-84.67%	23.99%	187.87%
Free Cash Flow Per Share	-	-	6.25	-8.00	1.95	14.04
Cash Interest Paid	1.47	-	-	0.09	0.09	-
Cash Income Tax Paid	-	-0.45	-0.46	0.05	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.